IL160242A0 - Methods for the treatment and prognosis of leukemia and other cancer types - Google Patents
Methods for the treatment and prognosis of leukemia and other cancer typesInfo
- Publication number
- IL160242A0 IL160242A0 IL16024202A IL16024202A IL160242A0 IL 160242 A0 IL160242 A0 IL 160242A0 IL 16024202 A IL16024202 A IL 16024202A IL 16024202 A IL16024202 A IL 16024202A IL 160242 A0 IL160242 A0 IL 160242A0
- Authority
- IL
- Israel
- Prior art keywords
- prognosis
- leukemia
- treatment
- methods
- cancer types
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57426—Specifically defined cancers leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2510/00—Detection of programmed cell death, i.e. apoptosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31025601P | 2001-08-07 | 2001-08-07 | |
PCT/IL2002/000649 WO2003013422A2 (en) | 2001-08-07 | 2002-08-07 | Methods for the treatment and prognosis of leukemia and other cancer types |
Publications (1)
Publication Number | Publication Date |
---|---|
IL160242A0 true IL160242A0 (en) | 2004-07-25 |
Family
ID=23201665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16024202A IL160242A0 (en) | 2001-08-07 | 2002-08-07 | Methods for the treatment and prognosis of leukemia and other cancer types |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1451218A4 (en) |
CA (1) | CA2456909A1 (en) |
IL (1) | IL160242A0 (en) |
WO (1) | WO2003013422A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1704414A4 (en) * | 2004-01-07 | 2008-04-16 | Rambam Medical Ct Funds For Me | Induction of apoptosis via arts-iap complexes |
US20150018285A1 (en) | 2012-02-15 | 2015-01-15 | Carmel-Haifa University Economic Corporation Ltd. | ANTAGONISTS OF Bcl-2 AND USES THEREOF IN INDUCTION OF APOPTOSIS |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3141107B2 (en) * | 1998-11-16 | 2001-03-05 | 工業技術院長 | Human-derived bradion protein, DNA encoding the same, and uses thereof |
AU2001231141A1 (en) * | 2000-01-29 | 2001-08-07 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Novel human septin and uses thereof |
-
2002
- 2002-08-07 IL IL16024202A patent/IL160242A0/en unknown
- 2002-08-07 EP EP02760520A patent/EP1451218A4/en not_active Withdrawn
- 2002-08-07 CA CA002456909A patent/CA2456909A1/en not_active Abandoned
- 2002-08-07 WO PCT/IL2002/000649 patent/WO2003013422A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2456909A1 (en) | 2003-02-20 |
EP1451218A4 (en) | 2006-03-08 |
WO2003013422A2 (en) | 2003-02-20 |
WO2003013422A3 (en) | 2004-05-21 |
EP1451218A2 (en) | 2004-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL251270A0 (en) | Cancer treatment | |
EG24356A (en) | Antitumor compounds and methods | |
AU6147401A (en) | Compositions and methods for the treatment of cancer | |
HK1086488A1 (en) | Compound and use thereof for the treatment of cancer | |
AU2002331290A1 (en) | Methods for the treatment of cancer with irinotecan based on cyp3a5 | |
AU2002348135A1 (en) | Methods for the treatment of addiction | |
EP1442062A4 (en) | Methods for the treatment of carcinoma | |
MXPA03008582A (en) | Agents and methods for treatment of cancer. | |
EP1509539A4 (en) | Novel compositions and methods for cancer | |
GB2389532C (en) | The method of treating cancer | |
PL368035A1 (en) | Compositions and methods for the treatment of cancer | |
EP1469769A4 (en) | Novel compositions and methods for cancer | |
MXPA03007036A (en) | Method of cancer therapy. | |
EP1401377A4 (en) | Methods for treating cancer | |
AU2003223538A1 (en) | Methods for the treatment of cancer | |
EP1469870A4 (en) | Novel compositions and methods for cancer | |
AU2002366195A8 (en) | Use of bisindolmaleimide and gemcitabine for the treatment of cancer | |
AU2002327643A1 (en) | Detection and treatment of cancers of the liver | |
IL160242A0 (en) | Methods for the treatment and prognosis of leukemia and other cancer types | |
AU2002304883A1 (en) | Device for the treatment of tumours | |
AU2004281077A1 (en) | Methods and agents for the treatment of cancer | |
AU2002305138A1 (en) | Methods and materials for cancer treatment | |
AU2002360454A8 (en) | Methods and compositions for treating cancer | |
WO2003020115A9 (en) | Methods and compositions for the detection of cancer | |
AU2001237414A1 (en) | Cancer treatment and prognosis |